3 Nov 2021

UC-II®️ Undenatured Type II Collagen

PDF 1.2 MB

Breakthrough in the competitive joint health & mobility category with UC-II®️ Undenatured Type II Collagen. This joint health ingredient is clinically proven to reduce joint discomfort and increase mobility by helping to repair and rebuild cartilage.

Content provided by our supplier

Capsugel Belgium NV

  • BE
  • 2015
    On CPHI since
Company types

Other Content from Capsugel Belgium NV (11)

  • News The Top 5 Industry Content Reads on CPHI Online

    If you’re looking for news, product information and market trends from leading pharma companies, the Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner. 

    The Company Showcase profiles offer a library of free to access, downloadable content, including videos and webinars, reports, whitepapers and product brochures, from the Pharma suppliers and service providers you’d look to meet at our events.

  • Brochure Capsugel®️ Vcaps®️ Plus capsules

    An immediate-release capsule for pharmaceutical products in HPMC only, without gelling agents. Vcaps®️ Plus capsules offer excellent dissolution profile with pH-independent performance, standard or low moisture content, great machinability and visual quality.
  • Brochure Capsugel®️ R&D Portfolio

    The Capsugel®️ R&D Portfolio addresses key concerns of R&D departments. Download the brochure to learn more about PCcaps®️ capsules for pre-clinical studies, DBcaps®️ capsules for double-blind clinical trials, the excellent dissolution profile of Vcaps®️ Plus capsules, Vcaps®️ Enteric capsules that simplify enteric drug delivery implementation, and Colorista®️ capsules, the perfect tool for flexible and time-efficient development of new products.  
  • Brochure Capsugel®️ Zephyr™️ Dry-Powder Inhalation Capsule Portfolio

    Dry-powder inhalation (DPI) technology offers a favorable drug development opportunity for respiratory or systemic drug delivery. Delivering a uniform dose in a portable, easy-to-use system, capsule-based DPI devices are a simple and cost-effective way to deliver inhalable medication. Capsugel® Zephyr™ is Lonza’s customizable dry-powder inhalation capsule portfolio that is optimized to provide superior performance and compatibility between the capsule/device and capsule/formulation.
  • Brochure High-quality capsules for the medicines of tomorrow

    The Capsugel® product portfolio is engineered to help overcome key product challenges with proven performance in products you trust. We are focused on quality and compliance in everything we do, from raw material sourcing to manufacturing and follow-up service. Our ongoing commitment to Six Sigma principles helps to minimize variability, improve the quality of our processes, and lead us toward the ultimate goal of zero defects for our products.
  • Brochure The Lonza Engine™ Alliance Program

    Our capsule filling equipment partnership program allows customers to match the best equipment for their process with the high-quality and performance of Capsugel®️ capsules.
  • Whitepaper Ingredients and formulation – evolving opportunities and challenges

    Ingredients are the lifeblood of the pharmaceutical and nutraceutical industries. They connect today’s cutting-edge medicine and consumer products makers with their origins in the chemicals sector of the late nineteenth century. While ingredients play a major part in determining whether a pharmaceutical or nutraceutical product is effective, they do not do it alone. How an ingredient is formulated is critical to the success of prescription medicine or OTC product, both therapeutically and from a commercial standpoint. This report looks at how the pharmaceutical and consumer health industries have risen to the challenge of making formulations that comply with evolving efficacy and safety demands while satisfying the needs of patients and consumers.
  • Video Oral Solid Dose Innovation

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. Forefront Key Formulation Variables & Approaches Formulation Development of Complex Oral Dosage Forms Discuss innovations & emergence of advanced technologies (e.g., 3D Printing) Main Driver and Areas of Growth for Oral-Dose Outsourcing Patient-Centric Innovation
  • Video The Importance of Colours and Why it Matters in the Pharmaceutical Market

    This session was originally broadcast as part of the CPHI Worldwide 2021 digital content programme. The session discusses: Colour in Health products: insights and perspectives The Colour Lab Services and how it can help you define your next coloured product Titanium dioxide discussion and Lonza CHI solutions
  • Video Value Added Excipients to Unlock the Potential of APIs

    This webinar originally aired as part of CPHI Discover - 17-28 May 2021 The humble excipient can play an important role in improving drug formulation, particularly in terms of solubility and stability. This session will explore how to add value to your drug development. Discussion points: The Vital Role Excipients play in producing new drugs and consumer products. An overview of Excipient Quality and Impact on Formulation Excipients Added to Solid Oral Dosage Forms to Improve Drug Solubility and/or Dissolution Latest Developments, demands & trends in the Excipients Market Examples of some Solutions, technologies, and regulatory changes happening on a global scale
  • Video Drug Delivery & Development: Overcoming Tomorrow’s Formulation Challenges

    This panel aims to provide an overview of the latest approaches to formulation and process challenges for drug development, manufacturing and supply, Highlighting a customized approach to optimize the performance of the end product. Our expert panel members will be sharing their views and experiences on the following key topics: Dry-powder inhalation (DPI) technology for favourable drug development and as a cost-effective and straightforward way to deliver inhalable medication, Drug Delivery Technologies for Women's Health Applications and 3D printing technologies reshaping drug discovery and pharmaceutical development and manufacturing. This presentation was originally aired as part of the CPHI Festival of Pharma.